国际呼吸杂志
國際呼吸雜誌
국제호흡잡지
INTERNATIONAL JOURNAL OF RESPIRATION
2011年
9期
648-650
,共3页
巫翠华%宋冰%黄立霞%钟春%马国珍%黄平
巫翠華%宋冰%黃立霞%鐘春%馬國珍%黃平
무취화%송빙%황립하%종춘%마국진%황평
咳嗽变异型哮喘%布地余德/福莫特罗%孟鲁司特钠
咳嗽變異型哮喘%佈地餘德/福莫特囉%孟魯司特鈉
해수변이형효천%포지여덕/복막특라%맹로사특납
Cough variation asthma%Budesonide/formoterol%Montelukast
目的 观察布地余德/福莫特罗(信必可)联合孟鲁司特钠(顺尔宁)治疗成人咳嗽变异型哮喘的疗效.方法 89例患者随机分成3组,治疗组吸入布地奈德/福莫特罗及服用孟鲁司特钠.对照组2组分别吸入布地奈德/福莫特罗或服用孟鲁司特钠.结果 3组治疗后的症状积分及肺功能较治疗前均有显著改善.且3组治疗后的症状积分及肺功能比较,治疗组优于布地奈德/福英特罗组,孟鲁司特钠组;经统计学处理,差异有统计学意义(P<0.05).结论布地奈德/福莫特罗与孟鲁司特钠联合应用在治疗咳嗽变异性哮喘的疗效优于单用布地奈德/福莫特罗、孟鲁司特钠.
目的 觀察佈地餘德/福莫特囉(信必可)聯閤孟魯司特鈉(順爾寧)治療成人咳嗽變異型哮喘的療效.方法 89例患者隨機分成3組,治療組吸入佈地奈德/福莫特囉及服用孟魯司特鈉.對照組2組分彆吸入佈地奈德/福莫特囉或服用孟魯司特鈉.結果 3組治療後的癥狀積分及肺功能較治療前均有顯著改善.且3組治療後的癥狀積分及肺功能比較,治療組優于佈地奈德/福英特囉組,孟魯司特鈉組;經統計學處理,差異有統計學意義(P<0.05).結論佈地奈德/福莫特囉與孟魯司特鈉聯閤應用在治療咳嗽變異性哮喘的療效優于單用佈地奈德/福莫特囉、孟魯司特鈉.
목적 관찰포지여덕/복막특라(신필가)연합맹로사특납(순이저)치료성인해수변이형효천적료효.방법 89례환자수궤분성3조,치료조흡입포지내덕/복막특라급복용맹로사특납.대조조2조분별흡입포지내덕/복막특라혹복용맹로사특납.결과 3조치료후적증상적분급폐공능교치료전균유현저개선.차3조치료후적증상적분급폐공능비교,치료조우우포지내덕/복영특라조,맹로사특납조;경통계학처리,차이유통계학의의(P<0.05).결론포지내덕/복막특라여맹로사특납연합응용재치료해수변이성효천적료효우우단용포지내덕/복막특라、맹로사특납.
Objective To investigate the efficacy of inhaled budcsonide/formoterol (symbicort)combined with oral montelukast (singulair) in the treatment of patients with cough variation asthma.Methods 89 cases with cough variation asthma were randomly divided into three groups. The cases of treatment group were treated by inhaled budesonide/formoterol in addition to oral montelukast. The cases of control groups receive budesonide/formotcrol or montelukast. Results After treatment, clinical symptom score and pulmonary function of the three groups were all improved. Compared with control groups the symptom score and pulmonary function of the treatment group are statistically different after treatment. Conclusions The improvement of symptom score and pulmonary function appears more obvisouly in treatment of cough variation asthma by inhaled budesonide/formoterol plus montelukast by using only one.